Welcome to our dedicated page for Allarity news (Ticker: ALLR), a resource for investors and traders seeking the latest updates and insights on Allarity stock.
Allarity Therapeutics, Inc. (NASDAQ: ALLR) is a clinical-stage biopharmaceutical company advancing personalized cancer therapies through its Drug Response Predictor (DRP®) platform. This page provides investors and industry professionals with timely updates on clinical trials, regulatory milestones, and strategic developments.
Access consolidated news on stenoparib’s progress in treating advanced ovarian cancer, DRP® companion diagnostic advancements, and partnership announcements. Our repository ensures efficient tracking of Allarity’s precision oncology innovations, from early-phase trial designs to late-stage data disclosures.
Content includes earnings reports, FDA communications, research collaborations, and scientific presentations. Each update is curated to highlight developments in patient selection methodologies and therapeutic efficacy without speculative commentary.
Bookmark this page for streamlined monitoring of Allarity’s contributions to targeted cancer treatment. Regularly updated to reflect the most current information available, this resource remains essential for understanding the company’s position in the evolving precision medicine landscape.
Allarity Therapeutics, Inc. (Nasdaq: ALLR) has priced a public offering to raise approximately $7.5 million through the sale of 2,869,330 shares of common stock, 7,130,670 pre-funded warrants, and 10 million common warrants. The combined price is set at $0.75 per share and common warrant, with warrants having an exercise price of $0.85 per share and a five-year expiration.
The closing is anticipated around April 21, 2023, subject to customary conditions. Funds will be used for accounts payable, accrued liabilities, and general corporate purposes, including redeeming series A preferred stock.
A.G.P./Alliance Global Partners is the sole placement agent for this offering. The securities are offered under a registration statement effective as of April 18, 2023.
FAQ
What is the current stock price of Allarity (ALLR)?
What is the market cap of Allarity (ALLR)?
